85-1444-12 β-Amyloid, aa1-40 1mg A2275-77F

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • Major constituent of plaques and tangles that occur in Alzheimer’s disease (AD) patients.
  • Sequence (linear): H2N-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val- Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly- Val-Val-OH
  • Amino Acid Analysis and Identity:Confirms expected sequence
  • Peptide Content: 80.92 ± 4%
  • Supplied As: Trifluoroacetate salt; 1.0 mg net peptide
  • Physical Appearance: Lyophilized powder
  • Solubility: H2O, TFA (trifluoroacetic acid), DMSO, HFIP (1,1,1,3,3,3-hexafluoro-2-propanol).
  • Solubility in H2O: 1 mg/mL.
  • Storage: -20ºC
  • Recommendations for Peptide Reconstitution:Preparing peptide for neurotoxicity studies, to induce peptide aggregation:The appearance of toxicity has recently been shown to correlate to the extent of beta sheet structure (S. Wang et al. [2001] J. Biol. Chem. 276(45):42027-42034). Recommended preincubation is:1. Dissolve the lyophilized peptide in 0.1% (v/v) trifluoroacetic acid in water at 10 mg/mL
  • 2. Dilute the peptide to 0.5–1.0 mg/mL with PBS (without Ca2+). 1. Incubate at 25°C for 24-48 h (24-36 h is usually sufficient). Neurotoxic activity is usually observed at 30-100ug/ml.
  • Preparing peptide for studies which require minimal peptide aggregation:1. Dissolve the peptide at a concentration of 1 mg/mL in 100% HFIP (1,1,1,3,3,3-hexafluoro-2-propanol [Sigma-Aldrich, 99.8% ACS reagent grade])
  • 2. Incubate at RT for 2 hours. During the incubation, vortex the peptide solution several times at moderate speed, allowing the HFIP to cover as much of the surface area as possible
  • 3. Dry down the HFIP/peptide solution under a gentle stream of nitrogen gas. Continue drying for an additional 10 minutes. Cap vial immediately
  • 4. Resuspend the peptide in 100% DMSO
  • 5. Incubate the peptide plus DMSO for 12 minutes at RT with periodic vortexing at moderate speed
  • 6. Add 50ul of this DMSO/peptide solution dropwise to 10ml of BSAT-DPBS (see formulation below) while vortexing at moderate speed. Peptides prepared in this manner have been used as standards in ELISA for the detection of beta amyloid in biological samples. When using this peptide in ELISA, it is important that the assay buffer used with the peptide standards has the same composition as the samples under investigation.
  • Buffer Formulations:DPBS Solution (10X Stock)Dulbecco’s PBS (DPBS w/o Mg2+, Ca2+)

仕様

  • Size:1mg
  • Purity:95+% HPLC, Mass Spec
  • Form:Supplied as a white to off-white lyophilized powder.
  • EU Commodity Code:38220090
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
85-1444-12
型番
A2275-77F
入り数
1個
標準価格
149,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る